RALINEPAG REDUCES PULMONARY VASCULAR RESISTANCE (PVR) IN A PHASE 2 STUDY CONFIRMING PRECLINICAL FINDINGS ON PROSTACYCLIN (IP) RECEPTORS IN HUMAN TISSUES
Ioana R. Preston, Lucie H. Clapp(The London College), Namita Sood, Lei Shen(University College London), Jigisha Patel(University College London), Linda Cadaret, John Adams
Cited by 1
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
|American Journal of Respiratory and Critical Care Medicine|2014|256
Vasopressin: Mechanisms of action on the vasculature in health and in septic shock
|Critical Care Medicine|2006|246